hyperaldosteronism |
Disease ID | 442 |
---|---|
Disease | hyperaldosteronism |
Manually Symptom | UMLS | Name(Total Manually Symptoms:15) C2364118 | weakness C1963138 | hypertension C1609519 | adrenal myelolipoma C1555754 | cardiovascular disease C1279412 | periodic paralysis syndrome C0334684 | renal adenoma C0232197 | fibrillation C0220983 | metabolic alkalosis C0206635 | myelolipoma C0162565 | acute intermittent porphyria C0033806 | pseudohypoparathyroidism C0020538 | vascular hypertension C0020488 | sodium retention C0010481 | hypercortisolism C0003125 | anorexia nervosa |
Text Mined Symptom | UMLS | Name | Sentences' Count(Total Symptoms:6) C0020538 | hypertension | 13 C0220983 | metabolic alkalosis | 4 C0001622 | hypercortisolism | 1 C0020488 | sodium retention | 1 C0206635 | myelolipoma | 1 C0334684 | renal adenoma | 1 |
Manually Genotype(Total Text Mining Genotypes:0) |
---|
(Waiting for update.) |
All Snps(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
GWASdb Annotation(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
GWASdb Snp Trait(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
Mapped by lexical matching(Total Items:0) |
---|
(Waiting for update.) |
Mapped by homologous gene(Total Items:0) |
---|
(Waiting for update.) |
Chemical(Total Drugs:6) | |||||||||
---|---|---|---|---|---|---|---|---|---|
CUI | ChemicalName | ChemicalID | CasRN | DiseaseName | DiseaseID | DirectEvidence | PubMedIDs | ||
C0020428 | bendroflumethiazide | D001539 | 73-48-3 | hyperaldosteronism | MESH:D006929 | therapeutic | 20009770 | ||
C0020428 | capreomycin | D002207 | 11003-38-6 | hyperaldosteronism | MESH:D006929 | marker/mechanism | 5489186 | ||
C0020428 | chlorthalidone | D002752 | 77-36-1 | hyperaldosteronism | MESH:D006929 | marker/mechanism | 1103606 | ||
C0020428 | spironolactone | D013148 | 1952/1/7 | hyperaldosteronism | MESH:D006929 | marker/mechanism | 1103606 | ||
C0020428 | spironolactone | D013148 | 1952/1/7 | hyperaldosteronism | MESH:D006929 | therapeutic | 19224505 | ||
C0020428 | streptozocin | D013311 | 18883-66-4 | hyperaldosteronism | MESH:D006929 | marker/mechanism | 2819817 |
FDA approved drug and dosage information(Total Drugs:0) | |
---|---|
(Waiting for update.) |
FDA labeling changes(Total Drugs:0) | |
---|---|
(Waiting for update.) |